The FDA is to review Sanofi/Regeneron's Dupixent as a treatment ... there is increasing competition in the asthma market, with AstraZeneca’s Fasenra (benralizumab) the latest in a new wave ...
“In asthma, Dupixent is quickly establishing a competitive ... and AstraZeneca’s Fasenra (benralizumab) all approved for eosinophilic asthma along with anti-immunoglobulin E drug Xolair ...
Please provide your email address to receive an email when new articles are posted on . Researchers assessed patients receiving omalizumab, dupilumab, mepolizumab, benralizumab, reslizumab or ...
Related News | US FDA Approves Dupixent Injections ... worldwide a year combined. Benralizumab is a safe and effective drug already used to manage severe asthma,” said lead investigator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback